Boehringer Ingelheim Corporation Clot-Buster Drug Didn’t Help Cardiac Arrest Survival

December 18, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Dec. 17 (Bloomberg) -- A clot-busting drug made by Boehringer Ingelheim GmbH didn’t improve the survival of patients who were treated away from a hospital after their hearts stopped functioning, a study found.

Twitter
LinkedIn
Facebook
Email
Print

Clinical research Postmarket research

Boehringer Ingelheim